BC
Broadwood Capital Portfolio holdings
AUM
$1.53B
This Quarter Return
+29.53%
1 Year Return
+36.91%
3 Year Return
+67.63%
5 Year Return
+132.65%
10 Year Return
+697.91%
AUM
$2.24B
AUM Growth
+$2.24B
(+20%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-6%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
STAAR Surgical
STAA
|
$134M |
Sector Composition
| 1 | Healthcare | 67.91% |
| 2 | Consumer Staples | 19.01% |
| 3 | Industrials | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
STAAR Surgical
STAA
$1.36B
| $1.32B | 59.06% | 8,664,239 -879,852 | -9% | -$134M |
|
2
Monster Beverage
MNST
$60.9B
| $425M | 19.01% | 4,656,488 | – | – |
|
3
iShares Russell 2000 ETF
IWM
$67B
| $158M | 7.07% | 690,000 | – | – |
|
4
Axon Enterprise
AXON
$58.7B
| $134M | 6.01% | 760,062 | – | – |
|
5
Lineage Cell Therapeutics
LCTX
$267M
| $96.9M | 4.33% | 34,005,379 | – | – |
|
|
IMDX
6
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $96.3M | 4.3% | 16,776,484 | – | – |
|
7
Serina Therapeutics
SER
$54.5M
| $4.65M | 0.21% | 2,997,156 | – | – |
|